1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biologics Manufacturing
1.2.3 Biosimilars Manufacturing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical Manufacturing
1.3.3 Commercial Manufacturing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO Services Market Perspective (2017-2028)
2.2 Biopharmaceutical CMO Services Growth Trends by Region
2.2.1 Biopharmaceutical CMO Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical CMO Services Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical CMO Services Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical CMO Services Market Dynamics
2.3.1 Biopharmaceutical CMO Services Industry Trends
2.3.2 Biopharmaceutical CMO Services Market Drivers
2.3.3 Biopharmaceutical CMO Services Market Challenges
2.3.4 Biopharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO Services Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical CMO Services Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO Services Revenue
3.4 Global Biopharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO Services Revenue in 2021
3.5 Biopharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO Services Breakdown Data by Type
4.1 Global Biopharmaceutical CMO Services Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical CMO Services Breakdown Data by Application
5.1 Global Biopharmaceutical CMO Services Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical CMO Services Market Size (2017-2028)
6.2 North America Biopharmaceutical CMO Services Market Size by Type
6.2.1 North America Biopharmaceutical CMO Services Market Size by Type (2017-2022)
6.2.2 North America Biopharmaceutical CMO Services Market Size by Type (2023-2028)
6.2.3 North America Biopharmaceutical CMO Services Market Share by Type (2017-2028)
6.3 North America Biopharmaceutical CMO Services Market Size by Application
6.3.1 North America Biopharmaceutical CMO Services Market Size by Application (2017-2022)
6.3.2 North America Biopharmaceutical CMO Services Market Size by Application (2023-2028)
6.3.3 North America Biopharmaceutical CMO Services Market Share by Application (2017-2028)
6.4 North America Biopharmaceutical CMO Services Market Size by Country
6.4.1 North America Biopharmaceutical CMO Services Market Size by Country (2017-2022)
6.4.2 North America Biopharmaceutical CMO Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO Services Market Size (2017-2028)
7.2 Europe Biopharmaceutical CMO Services Market Size by Type
7.2.1 Europe Biopharmaceutical CMO Services Market Size by Type (2017-2022)
7.2.2 Europe Biopharmaceutical CMO Services Market Size by Type (2023-2028)
7.2.3 Europe Biopharmaceutical CMO Services Market Share by Type (2017-2028)
7.3 Europe Biopharmaceutical CMO Services Market Size by Application
7.3.1 Europe Biopharmaceutical CMO Services Market Size by Application (2017-2022)
7.3.2 Europe Biopharmaceutical CMO Services Market Size by Application (2023-2028)
7.3.3 Europe Biopharmaceutical CMO Services Market Share by Application (2017-2028)
7.4 Europe Biopharmaceutical CMO Services Market Size by Country
7.4.1 Europe Biopharmaceutical CMO Services Market Size by Country (2017-2022)
7.4.2 Europe Biopharmaceutical CMO Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO Services Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biopharmaceutical CMO Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biopharmaceutical CMO Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO Services Market Size (2017-2028)
9.2 Latin America Biopharmaceutical CMO Services Market Size by Type
9.2.1 Latin America Biopharmaceutical CMO Services Market Size by Type (2017-2022)
9.2.2 Latin America Biopharmaceutical CMO Services Market Size by Type (2023-2028)
9.2.3 Latin America Biopharmaceutical CMO Services Market Share by Type (2017-2028)
9.3 Latin America Biopharmaceutical CMO Services Market Size by Application
9.3.1 Latin America Biopharmaceutical CMO Services Market Size by Application (2017-2022)
9.3.2 Latin America Biopharmaceutical CMO Services Market Size by Application (2023-2028)
9.3.3 Latin America Biopharmaceutical CMO Services Market Share by Application (2017-2028)
9.4 Latin America Biopharmaceutical CMO Services Market Size by Country
9.4.1 Latin America Biopharmaceutical CMO Services Market Size by Country (2017-2022)
9.4.2 Latin America Biopharmaceutical CMO Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO Services Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biopharmaceutical CMO Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biopharmaceutical CMO Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biopharmaceutical CMO Services Introduction
11.1.4 Lonza Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.1.5 Lonza Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Biopharmaceutical CMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 AGC Biologics
11.3.1 AGC Biologics Company Details
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics Biopharmaceutical CMO Services Introduction
11.3.4 AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.3.5 AGC Biologics Recent Developments
11.4 Rentschler Biotechnologie
11.4.1 Rentschler Biotechnologie Company Details
11.4.2 Rentschler Biotechnologie Business Overview
11.4.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Introduction
11.4.4 Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.4.5 Rentschler Biotechnologie Recent Developments
11.5 JRS Pharma
11.5.1 JRS Pharma Company Details
11.5.2 JRS Pharma Business Overview
11.5.3 JRS Pharma Biopharmaceutical CMO Services Introduction
11.5.4 JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.5.5 JRS Pharma Recent Developments
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Biopharmaceutical CMO Services Introduction
11.6.4 Catalent Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.6.5 Catalent Recent Developments
11.7 Biomeva
11.7.1 Biomeva Company Details
11.7.2 Biomeva Business Overview
11.7.3 Biomeva Biopharmaceutical CMO Services Introduction
11.7.4 Biomeva Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.7.5 Biomeva Recent Developments
11.8 Samsung BioLogics
11.8.1 Samsung BioLogics Company Details
11.8.2 Samsung BioLogics Business Overview
11.8.3 Samsung BioLogics Biopharmaceutical CMO Services Introduction
11.8.4 Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.8.5 Samsung BioLogics Recent Developments
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Biopharmaceutical CMO Services Introduction
11.9.4 AbbVie Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.9.5 AbbVie Recent Developments
11.10 Binex
11.10.1 Binex Company Details
11.10.2 Binex Business Overview
11.10.3 Binex Biopharmaceutical CMO Services Introduction
11.10.4 Binex Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.10.5 Binex Recent Developments
11.11 WuXi Biologics
11.11.1 WuXi Biologics Company Details
11.11.2 WuXi Biologics Business Overview
11.11.3 WuXi Biologics Biopharmaceutical CMO Services Introduction
11.11.4 WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.11.5 WuXi Biologics Recent Developments
11.12 PRA Health Sciences
11.12.1 PRA Health Sciences Company Details
11.12.2 PRA Health Sciences Business Overview
11.12.3 PRA Health Sciences Biopharmaceutical CMO Services Introduction
11.12.4 PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.12.5 PRA Health Sciences Recent Developments
11.13 ProBioGen
11.13.1 ProBioGen Company Details
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Biopharmaceutical CMO Services Introduction
11.13.4 ProBioGen Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.13.5 ProBioGen Recent Developments
11.14 KBI Biopharma
11.14.1 KBI Biopharma Company Details
11.14.2 KBI Biopharma Business Overview
11.14.3 KBI Biopharma Biopharmaceutical CMO Services Introduction
11.14.4 KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2017-2022)
11.14.5 KBI Biopharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Biologics Manufacturing
Table 3. Key Players of Biosimilars Manufacturing
Table 4. Key Players of Others
Table 5. Global Biopharmaceutical CMO Services Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Biopharmaceutical CMO Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Biopharmaceutical CMO Services Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Biopharmaceutical CMO Services Market Share by Region (2017-2022)
Table 9. Global Biopharmaceutical CMO Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Biopharmaceutical CMO Services Market Share by Region (2023-2028)
Table 11. Biopharmaceutical CMO Services Market Trends
Table 12. Biopharmaceutical CMO Services Market Drivers
Table 13. Biopharmaceutical CMO Services Market Challenges
Table 14. Biopharmaceutical CMO Services Market Restraints
Table 15. Global Biopharmaceutical CMO Services Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Biopharmaceutical CMO Services Revenue Share by Players (2017-2022)
Table 17. Global Top Biopharmaceutical CMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2021)
Table 18. Ranking of Global Top Biopharmaceutical CMO Services Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Biopharmaceutical CMO Services Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biopharmaceutical CMO Services Product Solution and Service
Table 22. Date of Enter into Biopharmaceutical CMO Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopharmaceutical CMO Services Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2017-2022)
Table 26. Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2023-2028)
Table 28. Global Biopharmaceutical CMO Services Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Biopharmaceutical CMO Services Revenue Share by Application (2017-2022)
Table 30. Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Biopharmaceutical CMO Services Revenue Share by Application (2023-2028)
Table 32. North America Biopharmaceutical CMO Services Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Biopharmaceutical CMO Services Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Biopharmaceutical CMO Services Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Biopharmaceutical CMO Services Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Biopharmaceutical CMO Services Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Biopharmaceutical CMO Services Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Biopharmaceutical CMO Services Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Biopharmaceutical CMO Services Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Biopharmaceutical CMO Services Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Biopharmaceutical CMO Services Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Biopharmaceutical CMO Services Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Biopharmaceutical CMO Services Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Biopharmaceutical CMO Services Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Biopharmaceutical CMO Services Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Biopharmaceutical CMO Services Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Biopharmaceutical CMO Services Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Biopharmaceutical CMO Services Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Biopharmaceutical CMO Services Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Biopharmaceutical CMO Services Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Biopharmaceutical CMO Services Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Biopharmaceutical CMO Services Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Biopharmaceutical CMO Services Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Biopharmaceutical CMO Services Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Biopharmaceutical CMO Services Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Biopharmaceutical CMO Services Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Biopharmaceutical CMO Services Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Biopharmaceutical CMO Services Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Biopharmaceutical CMO Services Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Biopharmaceutical CMO Services Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Biopharmaceutical CMO Services Market Size by Country (2023-2028) & (US$ Million)
Table 62. Lonza Company Details
Table 63. Lonza Business Overview
Table 64. Lonza Biopharmaceutical CMO Services Product
Table 65. Lonza Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 66. Lonza Recent Developments
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Biopharmaceutical CMO Services Product
Table 70. Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Developments
Table 72. AGC Biologics Company Details
Table 73. AGC Biologics Business Overview
Table 74. AGC Biologics Biopharmaceutical CMO Services Product
Table 75. AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 76. AGC Biologics Recent Developments
Table 77. Rentschler Biotechnologie Company Details
Table 78. Rentschler Biotechnologie Business Overview
Table 79. Rentschler Biotechnologie Biopharmaceutical CMO Services Product
Table 80. Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 81. Rentschler Biotechnologie Recent Developments
Table 82. JRS Pharma Company Details
Table 83. JRS Pharma Business Overview
Table 84. JRS Pharma Biopharmaceutical CMO Services Product
Table 85. JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 86. JRS Pharma Recent Developments
Table 87. Catalent Company Details
Table 88. Catalent Business Overview
Table 89. Catalent Biopharmaceutical CMO Services Product
Table 90. Catalent Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 91. Catalent Recent Developments
Table 92. Biomeva Company Details
Table 93. Biomeva Business Overview
Table 94. Biomeva Biopharmaceutical CMO Services Product
Table 95. Biomeva Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 96. Biomeva Recent Developments
Table 97. Samsung BioLogics Company Details
Table 98. Samsung BioLogics Business Overview
Table 99. Samsung BioLogics Biopharmaceutical CMO Services Product
Table 100. Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 101. Samsung BioLogics Recent Developments
Table 102. AbbVie Company Details
Table 103. AbbVie Business Overview
Table 104. AbbVie Biopharmaceutical CMO Services Product
Table 105. AbbVie Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 106. AbbVie Recent Developments
Table 107. Binex Company Details
Table 108. Binex Business Overview
Table 109. Binex Biopharmaceutical CMO Services Product
Table 110. Binex Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 111. Binex Recent Developments
Table 112. WuXi Biologics Company Details
Table 113. WuXi Biologics Business Overview
Table 114. WuXi Biologics Biopharmaceutical CMO Services Product
Table 115. WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 116. WuXi Biologics Recent Developments
Table 117. PRA Health Sciences Company Details
Table 118. PRA Health Sciences Business Overview
Table 119. PRA Health Sciences Biopharmaceutical CMO Services Product
Table 120. PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 121. PRA Health Sciences Recent Developments
Table 122. ProBioGen Company Details
Table 123. ProBioGen Business Overview
Table 124. ProBioGen Biopharmaceutical CMO Services Product
Table 125. ProBioGen Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 126. ProBioGen Recent Developments
Table 127. KBI Biopharma Company Details
Table 128. KBI Biopharma Business Overview
Table 129. KBI Biopharma Biopharmaceutical CMO Services Product
Table 130. KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 131. KBI Biopharma Recent Developments
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO Services Market Share by Type: 2021 VS 2028
Figure 2. Biologics Manufacturing Features
Figure 3. Biosimilars Manufacturing Features
Figure 4. Others Features
Figure 5. Global Biopharmaceutical CMO Services Market Share by Application: 2021 VS 2028
Figure 6. Clinical Manufacturing Case Studies
Figure 7. Commercial Manufacturing Case Studies
Figure 8. Others Case Studies
Figure 9. Biopharmaceutical CMO Services Report Years Considered
Figure 10. Global Biopharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Biopharmaceutical CMO Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Biopharmaceutical CMO Services Market Share by Region: 2021 VS 2028
Figure 13. Global Biopharmaceutical CMO Services Market Share by Players in 2021
Figure 14. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO Services Revenue in 2021
Figure 16. North America Biopharmaceutical CMO Services Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Biopharmaceutical CMO Services Market Size Market Share by Type (2017-2028)
Figure 18. North America Biopharmaceutical CMO Services Market Size Market Share by Application (2017-2028)
Figure 19. North America Biopharmaceutical CMO Services Market Size Share by Country (2017-2028)
Figure 20. United States Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Biopharmaceutical CMO Services Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Biopharmaceutical CMO Services Market Size Market Share by Type (2017-2028)
Figure 24. Europe Biopharmaceutical CMO Services Market Size Market Share by Application (2017-2028)
Figure 25. Europe Biopharmaceutical CMO Services Market Size Share by Country (2017-2028)
Figure 26. Germany Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Biopharmaceutical CMO Services Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Biopharmaceutical CMO Services Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Biopharmaceutical CMO Services Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Biopharmaceutical CMO Services Market Size Share by Region (2017-2028)
Figure 36. China Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Biopharmaceutical CMO Services Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Biopharmaceutical CMO Services Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Biopharmaceutical CMO Services Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Biopharmaceutical CMO Services Market Size Share by Country (2017-2028)
Figure 46. Mexico Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Biopharmaceutical CMO Services Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Biopharmaceutical CMO Services Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Biopharmaceutical CMO Services Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Biopharmaceutical CMO Services Market Size Share by Country (2017-2028)
Figure 52. Turkey Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Biopharmaceutical CMO Services Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Lonza Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 57. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 58. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 59. JRS Pharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 60. Catalent Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 61. Biomeva Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 62. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 63. AbbVie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 64. Binex Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 65. WuXi Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 66. PRA Health Sciences Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 67. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 68. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
